Hibernicor has been selected as a finalist for the Boston Pediatric Device Consortium Strategic Partner Challenge after a comprehensive review of applications conducted by the Boston Pediatric Device Consortium (BPDC), the Innovation & Digital Health Accelerator at Boston Children’s Hospital (IDHA), and partner organizations.

  • Date/Time: Wednesday, December 6th, 8:00 am – 6:00 pm
  • Location: 300 Longwood Avenue, Boston, MA, 02115

Challenge winners will receive a combination of up to $50,000 in funding and/or mentorship opportunities. Strategic partners – including Boston Scientific, CryoLife, Edwards Lifesciences, Health Advances, Johnson & Johnson Innovation, Smithwise, and Ximedica – will provide strategic support for challenge winners focused on accelerating winning innovations towards commercialization.

The Boston Pediatric Device Consortium (BPDC) provides expertise and resources to device developers and manufacturers at each of the steps necessary for novel pediatric device development, in order to accelerate the pace of innovation. The BPDC is a collaborative of experts in engineering, clinical sciences, clinical trials design and performance, device development specialists, and industry partners whose primary goal is to develop and evaluate novel therapies for children. Leading the BPDC is Pedro del Nido, MD, the Chief of the Department of Cardiac Surgery at Boston Children’s Hospital, the William E. Ladd Professor of Child Surgery at Harvard Medical School, and medical device entrepreneur.